Clinical Trial Update: Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI) [NA]

View source ↗

Summary

A completed clinical trial investigates whether early changes on PET/CT scans can predict outcomes for non-small cell lung cancer patients treated with EGFR tyr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EGFR Tyrosine Kinase Inhibitors (EGFR tyrosine kinase inhibitor)

Snippet

Sponsor: University of Aarhus | Conditions: Non-small Cell Lung Cancer Patients | NA | Status: COMPLETED